|
NDRG3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.09729999995001E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.35449999999427E-05 |
| Normal-vs-Stage2 |
1.161570E-04 |
| Normal-vs-Stage3 |
5.42250000012956E-07 |
| Normal-vs-Stage4 |
5.64570000000097E-05 |
| Stage1-vs-Stage2 |
4.624000E-01 |
| Stage1-vs-Stage3 |
2.522200E-02 |
| Stage1-vs-Stage4 |
4.331200E-01 |
| Stage2-vs-Stage3 |
3.995800E-01 |
| Stage2-vs-Stage4 |
9.620600E-01 |
| Stage3-vs-Stage4 |
3.159200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73682999999869E-05 |
| Normal-vs-AfricanAmerican |
2.006099999452E-07 |
| Normal-vs-Asian |
1.970820E-01 |
| Caucasian-vs-AfricanAmerican |
4.364300E-02 |
| Caucasian-vs-Asian |
1.829010E-01 |
| AfricanAmerican-vs-Asian |
1.674410E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.73849999998799E-06 |
| Normal-vs-Female |
4.40259999999748E-05 |
| Male-vs-Female |
3.724200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.395000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.11059999999375E-05 |
| Normal-vs-Age(61-80Yrs) |
2.06969999999584E-05 |
| Normal-vs-Age(81-100Yrs) |
8.648100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.259800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.246800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.356000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.964000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.527800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.515010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.187800E-02 |
| Normal-vs-Grade 2 |
6.13509999999318E-05 |
| Normal-vs-Grade 3 |
1.54974999999613E-05 |
| Normal-vs-Grade 4 |
1.131899999951E-06 |
| Grade 1-vs-Grade 2 |
4.844400E-01 |
| Grade 1-vs-Grade 3 |
3.149400E-01 |
| Grade 1-vs-Grade 4 |
1.176200E-01 |
| Grade 2-vs-Grade 3 |
3.337200E-01 |
| Grade 2-vs-Grade 4 |
6.304200E-02 |
| Grade 3-vs-Grade 4 |
2.728800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.597900E-04 |
| Normal-vs-ccB subtype |
1.55180000005473E-06 |
| ccA subtype-vs-ccB subtype |
1.225980E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.74129999999762E-06 |
| Normal-vs-N1 |
3.861600E-01 |
| N0-vs-N1 |
3.425800E-02 |
|
|
